FactSet's Q4 Earnings Beat Estimates, Revenues Increase 6.3% Y/Y

FactSet reported fiscal Q4 2026 adjusted EPS of $4.52, up 11.6% year over year and 4.6% above consensus, while revenue rose 6.3% to $634.7 million and exceeded estimates by 1.0%. Organic ASV increased 7.0% to $2.57 billion, retention remained above 95%, and fiscal-year AI solution ASV additions more than doubled. However, adjusted operating margin contracted 80bps to 33.0% and GAAP EPS fell 15.4% amid compensation, technology and restructuring costs; FY27 adjusted EPS guidance of $19.25-$19.65 is below the $19.84 consensus at the midpoint.

Analysis

FDS has converted incremental subscription growth into materially less operating leverage than a mature data-platform model should deliver. The key debate is therefore not retention but whether AI products are additive pricing power or simply a higher-cost feature set that protects the installed base; current guidance implies the latter. With EPS guidance below the Street despite continued repurchases, the near-term setup is a modest estimate-reset risk rather than a clean beat-and-raise rerating.

The more consequential competitive read-through is that enterprise financial-data buyers are extending contracts while likely consolidating vendors around workflow-integrated platforms. This favors scale incumbents such as LSEG and SPGI, whose broader datasets and embedded terminals can amortize generative-AI investment across a larger revenue base. FDS's faster APAC trajectory is strategically useful but too small to offset a sustained margin gap if compensation and technology spend remain elevated.

Over the next 1-3 months, watch sell-side FY27 EPS revisions, AI-product attach rates and net-new ASV rather than headline retention. A recovery in adjusted margin toward the upper end of guidance without deceleration in ASV would support multiple expansion; conversely, another quarter of low-single-digit operating-income growth would expose the stock to de-rating as buybacks become less accretive. Over 6-18 months, the upside case requires AI to reduce research workflow costs and allow price increases, not merely increase renewal duration.

Contrarian view: the market may over-penalize the margin decline if it is principally incentive timing and restructuring rather than permanent AI infrastructure inflation. But this is not yet independently verifiable from aggregate AI-ASV commentary; the relevant missing disclosure is AI revenue mix, gross retention by product cohort and associated cloud/model-inference expense.

Key Decisions for Investors

• Tactically avoid adding FDS into the immediate earnings reaction; reassess after the next 30-60 days of estimate revisions. Initiate only if FY27 consensus EPS moves toward the guided range and shares discount a sub-35% adjusted-margin outcome; thesis is invalidated if organic ASV falls below 5% or margin guidance is cut.
• Express relative quality via long SPGI / short FDS over a 3-6 month horizon, sized beta-neutral. The trade captures broader data/workflow scale and lower AI-investment concentration at SPGI; cover if FDS demonstrates two consecutive quarters of margin expansion while maintaining at least 6.5% organic ASV growth.
• Maintain DOCU as a separate, higher-beta software watch rather than treating the FDS result as a sector signal. If DOCU's AI-enabled agreement workflow drives sustained high-single-digit growth with expanding margins, it offers a cleaner operating-leverage setup; require evidence in the next earnings release before initiating.
• Do not infer an actionable QBTS read-through from this release. Enterprise AI adoption at data vendors does not establish demand for quantum computing; wait for disclosed bookings, backlog conversion, or commercial contract economics.